Misleading drug promotion--no sign of improvements.

Pharmacoepidemiol Drug Saf

Published: November 2004

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.953DOI Listing

Publication Analysis

Top Keywords

misleading drug
4
drug promotion--no
4
promotion--no sign
4
sign improvements
4
misleading
1
promotion--no
1
sign
1
improvements
1

Similar Publications

Health care decisions are increasingly informed by clinical decision support algorithms, but these algorithms may perpetuate or increase racial and ethnic disparities in access to and quality of health care. Further complicating the problem, clinical data often have missing or poor quality racial and ethnic information, which can lead to misleading assessments of algorithmic bias. We present novel statistical methods that allow for the use of probabilities of racial/ethnic group membership in assessments of algorithm performance and quantify the statistical bias that results from error in these imputed group probabilities.

View Article and Find Full Text PDF

Background: Prescription drugs may be indicated to treat more than one medical condition, and companies may promote more than one indication in the same direct-to-consumer (DTC) ad. This study examined how presenting multiple prescription drug indications in one DTC television ad affects consumers' processing of drug information.

Methods: We conducted two studies with adults diagnosed with diabetes (Study 1, N = 408) or rheumatoid arthritis (Study 2, N = 411).

View Article and Find Full Text PDF

Motivation: Accurately identifying ligands plays a crucial role in the process of structure-guided drug design. Based on density maps from X-ray diffraction or cryogenic-sample electron microscopy (cryoEM), scientists verify whether small-molecule ligands bind to active sites of interest. However, the interpretation of density maps is challenging, and cognitive bias can sometimes mislead investigators into modeling fictitious compounds.

View Article and Find Full Text PDF

Misleading Renal Function Evaluation Leading to Severe Methotrexate-Induced Toxicity.

Ther Drug Monit

December 2024

Université Jean Monnet, Médecine Intensive Réanimation G, CHU Saint-Etienne, INSERM, Mines Saint Etienne, Saint-Étienne, France.

Low-dose methotrexate has been proposed as therapy for patients with severely disabling psoriasis and psoriatic arthritis. However, it can be associated with severe toxicity, such as pancytopenia, characterized by anemia (hemoglobin level <13 g/dL in men), thrombocytopenia (platelet count <150 × 109/L), and neutropenia or agranulocytosis (neutrophil count <1.5 × 109/L and 0.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores how many US adults believe that "organic" and "additive-free" tobacco products are less harmful compared to regular tobacco, particularly focusing on differences among smokers and those who prefer the Natural American Spirit brand.
  • Analyzing data from over 29,000 participants, the research finds that a notable percentage of adults, especially young adults and smokers, have these beliefs, with the strongest convictions among those who currently smoke.
  • The findings suggest that despite the risks of tobacco use, many smokers hold on to the perception that these alternative products are safer, highlighting the need for better public education regarding tobacco harm.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!